Keenova Therapeutics plc·4

Jun 4, 4:12 PM ET

Dorton Katina 4

Research Summary

AI-generated summary

Updated

Keenova Director Dorton Katina Receives 4,882 Shares (RSU Settlement)

What Happened

  • Director Dorton Katina had 4,882 restricted stock units (RSUs) settle into 4,882 ordinary shares on June 2, 2026. The filing also reports a simultaneous disposal of 4,882 shares at $0.00, resulting in no cash proceeds reported. The Form 4 uses transaction code M (exercise/conversion of a derivative) to reflect the settlement/conversion.

Key Details

  • Transaction date: 2026-06-02; Form 4 filed: 2026-06-04 (timely filing).
  • Acquired: 4,882 shares via RSU settlement (price N/A per share). Disposed: 4,882 shares at $0.00 (no cash proceeds reported).
  • Shares owned after transaction: not specified in the provided excerpt.
  • Footnotes: F1 — each RSU settled into one ordinary share; F2 — RSUs were granted Aug 14, 2025 and vest on the earlier of the first anniversary of the grant or the issuer’s next annual general meeting.
  • Transaction code: M = exercise/conversion of derivative (here, RSU settlement).

Context

  • This was an RSU settlement (award conversion), not an open-market purchase or sale. The simultaneous $0.00 disposition is commonly used to reflect shares withheld or converted to satisfy tax or similar obligations on settlement; the filing shows no cash proceeds. Such award settlements are routine and do not necessarily indicate a change in insider sentiment.